The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Huvebiotic 330 mg/100 mg Intramammary solution

Huvepharma NVVPA10782/037/001

Main Information

Trade NameHuvebiotic 330 mg/100 mg Intramammary solution
Active SubstancesNeomycin sulfate
Lincomycin hydrochloride
Dosage FormIntramammary solution
Licence HolderHuvepharma NV
License Holder AddressUitbreidingstraat 80
2600 Antwerpen
Licence NumberVPA10782/037/001

Group Information

ATC CodeQJ51RF03 lincomycin, combinations with other antibacterials
QJ51RG01 neomycin, combinations with other antibacterials
Therapeutic ClassAntibacterial


License statusAuthorised
Licence Issued29/10/2021
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
VariationsPDF Version

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back